chr1-103534778-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000423855.7(RNPC3):c.364G>A(p.Asp122Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000263 in 1,523,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000423855.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNPC3 | NM_017619.4 | c.364G>A | p.Asp122Asn | missense_variant | 4/15 | ENST00000423855.7 | NP_060089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNPC3 | ENST00000423855.7 | c.364G>A | p.Asp122Asn | missense_variant | 4/15 | 1 | NM_017619.4 | ENSP00000391432.1 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151310Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000218 AC: 3AN: 137522Hom.: 0 AF XY: 0.0000271 AC XY: 2AN XY: 73790
GnomAD4 exome AF: 0.00000219 AC: 3AN: 1371992Hom.: 0 Cov.: 28 AF XY: 0.00000295 AC XY: 2AN XY: 677680
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151310Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73848
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.364G>A (p.D122N) alteration is located in exon 1 (coding exon 1) of the RNPC3 gene. This alteration results from a G to A substitution at nucleotide position 364, causing the aspartic acid (D) at amino acid position 122 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at